Blackrock Health Sciences Trust (BME) Financials
BME Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-10-31 | 596.1 million | 8.0 million |
| 2023-04-30 | 607.8 million | 10.5 million |
| 2023-01-31 | 607.8 million | 10.5 million |
| 2022-10-31 | 606.1 million | 5.9 million |
BME Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-10-31 | -1.7 million | ? |
| 2023-04-30 | 6.5 million | ? |
| 2023-01-31 | 7.0 million | ? |
| 2022-10-31 | 462666 | ? |
BME Net Income
| Date | Net Income |
|---|---|
| 2023-10-31 | 8.7 million |
| 2023-04-30 | 11.3 million |
| 2023-01-31 | 5.7 million |
| 2022-10-31 | 35.8 million |
BME Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-10-31 | 31.4 million | - | - |
| 2023-04-30 | 28.1 million | - | - |
| 2023-01-31 | 606 | - | - |
| 2022-10-31 | 23.9 million | - | - |
BME Shares Outstanding
BME Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-10-31 | - | - | - | - |
| 2023-04-30 | - | - | 1.5 million | - |
| 2023-01-31 | - | - | 1.5 million | - |
| 2022-10-31 | - | - | 1.6 million | - |
BME Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-10-31 | 18.3 million | 3.0 million |
| 2023-04-30 | 16.6 million | 3.0 million |
| 2023-01-31 | 2.1 million | - |
| 2022-10-31 | 538987 | 3.0 million |
BME
Price: $39.48
Dividend Yield: 0.06%
Forward Dividend Yield: 6.47%
Payout Ratio: 74.30%
Dividend Per Share: 2.56 USD
Earnings Per Share: 1.44 USD
P/E Ratio: 12.01
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Volume: 21500
Market Capitalization: 549.3 million
Average Dividend Frequency: 8
Years Paying Dividends: 20
DGR3: 2.13%
DGR5: 1.28%
DGR10: 5.83%